Pharmacovigilance system development

With amendments to Regulations (EC) 726/2004 and 520/2012 as well as Directive 2001/83/EC in recent years, the requirements for monitoring drug safety have become greatly formalised. The qualified person for pharmacovigilance (QPPV) is responsible for establishing and maintaining a company’s pharmacovigilance system.

We act in this capacity for pharmaceutical companies by performing a number of services, including the following:

  • Evaluation of existing pharmacovigilance activities (SOPs, literature research, reporting, PSURs, alarm plans, etc.) and measures to minimise risk
  • Establishing and summarising pharmacovigilance systems (pharmacovigilance system master file, PSMF) for pharmaceutical companies, including annexes
  • Compilation of risk management plans (RMP)
  • Conducting internal audits
  • Preparation for and assistance with inspections by regulatory authorities

Summary PSMF for marketing authorisation

A summary of the pharmacovigilance system master file (summary PSMF) and risk management plans are a necessary part of most applications for marketing authorisation. We can help compile and present the required documents completely and efficiently.

Photo:  Tessa van Alen
Dr. Tessa van Alen
Senior Consultant
Photo:  Jasmin Beermann
Dr. Jasmin Beermann
Consultant
  1. Contact us!
  2. Service hotline: +49 251 609350 
    +43 1 5321606 
    +31 133029063 
    +86 21 6057 7019 

  3. E-Mail: info@diapharm.com

  4. Salutation*

This website uses cookies

We use cookies to improve the user experience. By continuing to use this website, you consent to the use of cookies.